Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enrich Biosystems is a U.S.-based life science tools company developing high-throughput, microfluidics-free cell discovery and live-cell retrieval systems for research and therapeutic development. Its flagship TROVO platform uses light-based microgel lithography, imaging, and AI-enabled analysis to create, monitor, and retrieve thousands of microcultures in standard lab plates. The company positions the platform for applications including cell therapy discovery, antibody screening, single-cell omics sample preparation, and cell line development. Enrich Biosystems appears to be an active private company headquartered in Branford, Connecticut, and was previously known as Enrich Therapeutics. It is best characterized as a research tools and instrumentation company serving biotech and pharma rather than a drug developer with a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ENRICH in the USA.